142 related articles for article (PubMed ID: 2261956)
1. "Protracted pulse" chemotherapy for refractory myeloma: a preliminary report.
Manoharan A
Eur J Haematol; 1990 Nov; 45(5):274-5. PubMed ID: 2261956
[No Abstract] [Full Text] [Related]
2. Alternating combination chemotherapy does not delay development of refractoriness in myeloma.
Osby E; Beksac M; Reizenstein P
Anticancer Res; 1986; 6(5):1145-7. PubMed ID: 3800322
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
Takagi T; Oguro M; Sakai C
Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977
[No Abstract] [Full Text] [Related]
4. [Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone].
Sezaki T; Ishii H; Osada T; Adachi T; Takahashi I; Ohnoshi T; Kimura I
Rinsho Ketsueki; 1982 Jun; 23(6):847-53. PubMed ID: 7176091
[No Abstract] [Full Text] [Related]
5. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
[No Abstract] [Full Text] [Related]
6. [Clinical study on chemotherapy for multiple myeloma. Part II: Prognostic factors of treatment with prednisolone and sequential melphalan and ifosfamide: MIP therapy].
Sezaki T; Ishii H; Adachi T; Takahashi I; Ohnoshi T; Kimura I
Rinsho Ketsueki; 1983 Apr; 24(4):433-9. PubMed ID: 6887543
[No Abstract] [Full Text] [Related]
7. [Cyclical chemotherapy of myeloma with cell synchronization: therapeutic trial. Apropos of 13 cases].
Roux H; D'Omezon Y; Lagier C; Thouveny F; Recordier AM
Rev Rhum Mal Osteoartic; 1976 Feb; 43(2):113-6. PubMed ID: 772787
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime.
Azam L; Delamore IW
Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684
[No Abstract] [Full Text] [Related]
9. Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma.
Kabir AL; Rahman MJ; Begum M; Dipta TF; Baqui MN; Aziz A; Rahman F; Debnath RC; Habib MA
Mymensingh Med J; 2012 Jan; 21(1):114-9. PubMed ID: 22314465
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy of multiple myeloma].
Uzuka Y; Saito Y; Ito T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1481-7. PubMed ID: 2389944
[TBL] [Abstract][Full Text] [Related]
11. [Comparative studies of intermittent melphalan and prednisolone (MP) versus 5-drug regimen (QUVMP) and 3-drug regimen (QUP) in multiple myeloma].
Hoshino S; Saito H; Wada M; Akutsu M; Shiozaki H; Takanashi M; Takei Y; Tanaka S; Teramura M; Takada K
Rinsho Ketsueki; 1987 Mar; 28(3):358-65. PubMed ID: 3475485
[No Abstract] [Full Text] [Related]
12. [Trial of combination chemotherapy for multiple myeloma and macroglobulinemia--VENAP therapy (author's transl)].
Furukawa K; Fujiwara Y; Nakaide Y; Tanaka M; Tanaka M; Hirota Y
Rinsho Ketsueki; 1980 Nov; 21(11):1683-91. PubMed ID: 6782278
[No Abstract] [Full Text] [Related]
13. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
Lila AM; Mazurov VI; Novik AA
Ter Arkh; 1997; 69(2):50-2. PubMed ID: 9173578
[No Abstract] [Full Text] [Related]
14. [Assessment of a nitrosurea combined with cyclophosphamide and prednisone versus melphalan and prednisone in the treatment of multiple myeloma (author's transl)].
Bezares R; Bomchil G; Saslavsky J; Pavlovsky S; Curutchet M; Quiroga Micheo E; Macchi A; Musso A; Suárez A; Pizzolato M
Sangre (Barc); 1979; 24(3):241-51. PubMed ID: 472966
[No Abstract] [Full Text] [Related]
15. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
[TBL] [Abstract][Full Text] [Related]
16. Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
Buonanno G; Tortarolo M; Valente A; Castaldo C; Russolillo S; Gonnella F
Haematologica; 1978 Feb; 63(1):45-55. PubMed ID: 417971
[No Abstract] [Full Text] [Related]
17. [Combined treatment, polychemotherapy and amino-hydroxybutylidene-diphosphonate, of a patient with multiple myeloma: remission and long survival].
Attardo-Parrinello G; Merlini G; Crema F; Fiorentini ML; Mazzone A; Cotti-Piccinelli E
Medicina (Firenze); 1988; 8(3):318-20. PubMed ID: 3231044
[No Abstract] [Full Text] [Related]
18. [A case of multiple myeloma responding very well to the combination of K18 with prednisolone].
Ishioka C; Kanamaru R; Sato T; Konishi Y; Himori T; Mimata Y; Wakui A
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1164-6. PubMed ID: 2436580
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
[No Abstract] [Full Text] [Related]
20. [Therapy of paraproteinemic hemoblastoses].
Fereberger W
Acta Med Austriaca; 1982; 9(4):151-7. PubMed ID: 6814158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
